Biodesix (BDSX) Amortization of Deferred Charges (2019 - 2021)

Biodesix (BDSX) has reported Amortization of Deferred Charges for 3 consecutive years, with $41000.0 the latest figure, recorded in Q1 2021.

• Amortization of Deferred Charges for Q1 2021 came in at $41000.0, up 13.89% year-over-year; the trailing twelve-month figure through Mar 2021 was $147000.0 (changed N/A YoY), and the FY2020 annual result was $144000.0, changed 0.0% from the prior year.
• Amortization of Deferred Charges was $41000.0 for Q1 2021 at Biodesix, up from $35000.0 in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $41000.0 in Q1 2021 and troughed at $35000.0 in Q4 2019.
• Average Amortization of Deferred Charges over 3 years is $36750.0, with a median of $35500.0 recorded in 2019.
• Year-over-year, Amortization of Deferred Charges changed 0.0% in 2020 and increased 13.89% in 2021.
• Over 3 years, Amortization of Deferred Charges stood at $35000.0 in 2019, then changed by 0.0% to $35000.0 in 2020, then climbed by 17.14% to $41000.0 in 2021.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $41000.0 in Q1 2021, $35000.0 in Q4 2020, and $36000.0 in Q1 2020.